177 related articles for article (PubMed ID: 32703181)
1. An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China.
Zhang L; Sun BC; Zhao BG; Ma QS
BMC Nephrol; 2020 Jul; 21(1):294. PubMed ID: 32703181
[TBL] [Abstract][Full Text] [Related]
2. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
3. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
5. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
6. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
Haas M
Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
[TBL] [Abstract][Full Text] [Related]
7. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological features of Alport syndrome in children].
Zhu CH; Huang SM; Wu HM; Bao HY; Chen Y; Han Y; Zhao F; Zhang AH; Zhang WZ
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):188-91. PubMed ID: 20350427
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
11. Familial hematuria: A review.
Plevová P; Gut J; Janda J
Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological features and the misdiagnosis of childhood Alport syndrome: a retrospective analysis of 91 cases].
Chen YZ; Sun LZ; Wang HY; Jiang XY; Mo Y; Yue ZH; Chen HM; Liu T; Lin HR
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):371-375. PubMed ID: 28407818
[TBL] [Abstract][Full Text] [Related]
13. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological study of 47 cases with Alport syndrome].
He X; Liu GL; Xia ZK; Ren XG; Gao YF; Fan ZM; Fu YF; Fu J; Gao CL; Mao S; Chen R
Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):914-8. PubMed ID: 19134254
[TBL] [Abstract][Full Text] [Related]
15. Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease.
Uzzo M; Moroni G; Ponticelli C
Nephron; 2023; 147(7):383-391. PubMed ID: 36882005
[TBL] [Abstract][Full Text] [Related]
16. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
[TBL] [Abstract][Full Text] [Related]
17. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
18. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
19. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
[TBL] [Abstract][Full Text] [Related]
20. [Alport syndrome or progressive hereditary nephritis with hearing loss].
Gubler MC; Heidet L; Antignac C
Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
